TheNote.app
Science Magazine | AAAS: Science Advances

Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor | Science Advances

NKG2A antibody blockade and bispecific NKG2A engagers enhance NK and T cell antitumor activity.
favicon
science.org
science.org
Image for the article: Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor | Science Advances
RSS Hunter
Create attached notes ...